CN113116750A - Polyol composition and application thereof in cosmetics - Google Patents
Polyol composition and application thereof in cosmetics Download PDFInfo
- Publication number
- CN113116750A CN113116750A CN202110473784.XA CN202110473784A CN113116750A CN 113116750 A CN113116750 A CN 113116750A CN 202110473784 A CN202110473784 A CN 202110473784A CN 113116750 A CN113116750 A CN 113116750A
- Authority
- CN
- China
- Prior art keywords
- skin
- polyol composition
- panthenol
- propanediol
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 82
- 229920005862 polyol Polymers 0.000 title claims abstract description 80
- 150000003077 polyols Chemical class 0.000 title claims abstract description 78
- 239000002537 cosmetic Substances 0.000 title claims abstract description 22
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 53
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 32
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims abstract description 26
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims abstract description 26
- 229940101267 panthenol Drugs 0.000 claims abstract description 26
- 235000020957 pantothenol Nutrition 0.000 claims abstract description 26
- 239000011619 pantothenol Substances 0.000 claims abstract description 26
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 23
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 21
- 229960004063 propylene glycol Drugs 0.000 claims abstract description 21
- 229940015975 1,2-hexanediol Drugs 0.000 claims abstract description 16
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims abstract description 16
- 235000013772 propylene glycol Nutrition 0.000 claims abstract description 14
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 claims abstract description 12
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims abstract description 12
- 229940035437 1,3-propanediol Drugs 0.000 claims abstract description 12
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims abstract description 12
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 claims abstract description 9
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000011159 matrix material Substances 0.000 claims abstract description 4
- 230000003020 moisturizing effect Effects 0.000 claims description 24
- 230000002087 whitening effect Effects 0.000 claims description 23
- 235000011187 glycerol Nutrition 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 238000005282 brightening Methods 0.000 claims description 13
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 12
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 11
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 10
- 206010040829 Skin discolouration Diseases 0.000 claims description 8
- -1 idebene Chemical compound 0.000 claims description 8
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 7
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 7
- 229940106189 ceramide Drugs 0.000 claims description 7
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 7
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 7
- 108010024636 Glutathione Proteins 0.000 claims description 6
- 229960003180 glutathione Drugs 0.000 claims description 6
- SSISHJJTAXXQAX-ZETCQYMHSA-N L-ergothioneine Chemical compound C[N+](C)(C)[C@H](C([O-])=O)CC1=CNC(=S)N1 SSISHJJTAXXQAX-ZETCQYMHSA-N 0.000 claims description 5
- 229940093497 ergothioneine Drugs 0.000 claims description 5
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 5
- 229940032094 squalane Drugs 0.000 claims description 5
- 239000000758 substrate Substances 0.000 claims description 5
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 4
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 4
- 239000011570 nicotinamide Substances 0.000 claims description 4
- 239000000661 sodium alginate Substances 0.000 claims description 4
- 235000010413 sodium alginate Nutrition 0.000 claims description 4
- 229940005550 sodium alginate Drugs 0.000 claims description 4
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 4
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 4
- 229960003966 nicotinamide Drugs 0.000 claims description 3
- 235000005152 nicotinamide Nutrition 0.000 claims description 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 3
- KOGFZZYPPGQZFZ-QVAPDBTGSA-N (2s,3r,4s,5r)-2-(2-hydroxypropyl)oxane-3,4,5-triol Chemical compound CC(O)C[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O KOGFZZYPPGQZFZ-QVAPDBTGSA-N 0.000 claims description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 2
- ZGSCRDSBTNQPMS-UJURSFKZSA-N 3-O-Ethylascorbic acid Chemical compound CCOC1=C(O)C(=O)O[C@@H]1[C@@H](O)CO ZGSCRDSBTNQPMS-UJURSFKZSA-N 0.000 claims description 2
- 229940120145 3-o-ethylascorbic acid Drugs 0.000 claims description 2
- 229920002498 Beta-glucan Polymers 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 2
- 102000008186 Collagen Human genes 0.000 claims description 2
- 108010035532 Collagen Proteins 0.000 claims description 2
- 241000530268 Lycaena heteronea Species 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 2
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims description 2
- 241000221095 Simmondsia Species 0.000 claims description 2
- 235000004433 Simmondsia californica Nutrition 0.000 claims description 2
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims description 2
- UYZLQWUFBLEIAJ-UHFFFAOYSA-N [hydroxy(dimethyl)silyl] 2-hydroxybenzoate Chemical compound C[Si](C)(O)OC(=O)C1=CC=CC=C1O UYZLQWUFBLEIAJ-UHFFFAOYSA-N 0.000 claims description 2
- 229940024606 amino acid Drugs 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 229960003237 betaine Drugs 0.000 claims description 2
- 229920001436 collagen Polymers 0.000 claims description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 2
- WQXNXVUDBPYKBA-YFKPBYRVSA-N ectoine Chemical compound CC1=[NH+][C@H](C([O-])=O)CCN1 WQXNXVUDBPYKBA-YFKPBYRVSA-N 0.000 claims description 2
- 229920001184 polypeptide Polymers 0.000 claims description 2
- 235000021283 resveratrol Nutrition 0.000 claims description 2
- 229940016667 resveratrol Drugs 0.000 claims description 2
- 229930002330 retinoic acid Natural products 0.000 claims description 2
- 235000020944 retinol Nutrition 0.000 claims description 2
- 229960003471 retinol Drugs 0.000 claims description 2
- 239000011607 retinol Substances 0.000 claims description 2
- 229940023561 silanediol salicylate Drugs 0.000 claims description 2
- 235000010384 tocopherol Nutrition 0.000 claims description 2
- 229960001295 tocopherol Drugs 0.000 claims description 2
- 229930003799 tocopherol Natural products 0.000 claims description 2
- 239000011732 tocopherol Substances 0.000 claims description 2
- 229960001727 tretinoin Drugs 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 27
- 238000010521 absorption reaction Methods 0.000 abstract description 11
- 230000014759 maintenance of location Effects 0.000 abstract description 11
- 150000005846 sugar alcohols Polymers 0.000 abstract description 9
- 239000003755 preservative agent Substances 0.000 abstract description 3
- 230000002335 preservative effect Effects 0.000 abstract description 3
- 230000000638 stimulation Effects 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 description 65
- 230000000052 comparative effect Effects 0.000 description 32
- 238000012360 testing method Methods 0.000 description 28
- 239000000047 product Substances 0.000 description 27
- 239000000686 essence Substances 0.000 description 18
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 9
- 229920002674 hyaluronan Polymers 0.000 description 9
- 229960003160 hyaluronic acid Drugs 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 230000035515 penetration Effects 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 230000002708 enhancing effect Effects 0.000 description 6
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 206010040914 Skin reaction Diseases 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 230000036564 melanin content Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000003961 penetration enhancing agent Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000035483 skin reaction Effects 0.000 description 4
- 231100000430 skin reaction Toxicity 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 229940107161 cholesterol Drugs 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 2
- 239000002390 adhesive tape Substances 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 239000007933 dermal patch Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000008236 heating water Substances 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- 238000011076 safety test Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 102000020313 Cell-Penetrating Peptides Human genes 0.000 description 1
- 108010051109 Cell-Penetrating Peptides Proteins 0.000 description 1
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N Lactic Acid Natural products CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 1
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 208000016252 change in skin color Diseases 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- PXGZQGDTEZPERC-UHFFFAOYSA-L cyclohexane-1,4-dicarboxylate Chemical compound [O-]C(=O)C1CCC(C([O-])=O)CC1 PXGZQGDTEZPERC-UHFFFAOYSA-L 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- AERBNCYCJBRYDG-KSZLIROESA-N phytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO AERBNCYCJBRYDG-KSZLIROESA-N 0.000 description 1
- 229940033329 phytosphingosine Drugs 0.000 description 1
- 229940113115 polyethylene glycol 200 Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 230000037067 skin hydration Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
The present invention relates to a polyol composition and its use in cosmetics, said polyol composition comprising: panthenol, 1, 2-propanediol, 1, 3-propanediol, and polyethylene glycol. Further, the polyol composition further comprises any one of glycerol, butanediol or 1, 2-hexanediol, or a combination of at least two thereof. Further, the polyol composition further comprises dipropylene glycol and/or pentanediol. The polyalcohol composition is added into skin care matrixes with different effects, so that the problem of transdermal absorption of skin care effect components can be remarkably improved, the efficacy of the product is improved, the absorptivity and moisture retention of the product are improved, the smearing feeling and the sticky feeling of the product are improved, no preservative is required to be added, and the skin care matrix is safe and mild and has no stimulation to skin.
Description
Technical Field
The invention belongs to the technical field of cosmetics, and particularly relates to a polyol composition and application thereof in cosmetics, in particular to a polyol composition with a remarkable permeation promoting effect and application thereof in cosmetics.
Background
The transdermal absorption effect of cosmetics is very important, which is a key point affecting whether cosmetics are effective or not. The prior art relates to a plurality of transdermal penetration promoting components, such as polyalcohol, lipoid, humectant, transdermal enhancing peptide and the like. Wherein the polyhydric alcohol comprises glycerol, propylene glycol, 1, 3-butanediol, 1, 2-hexanediol, pentanediol, etc.; the lipid comprises ceramide, cholesterol, squalane, egg yolk lecithin, soybean lecithin, hydrogenated lecithin, etc.; the humectant comprises bis-diethoxydiol cyclohexane 1, 4-dicarboxylate, caprylic/capric triglyceride, PEG/PPG-14/7 dimethyl ether, hydrolyzed glycosaminoglycans, shea butter, PEG castor oil, etc.; transdermal enhancing peptides include transdermal peptide TD-1, skin and cell penetrating peptide SPACE, dermal localization peptide DLP, leader peptide-12, T2 peptide, etc.
CN112245366A discloses a penetration-promoting composition containing hyaluronic acid and its application in cosmetics, comprising: 2-5 parts of hyaluronic acid, 1-3 parts of bis-diethoxydiol cyclohexane 1, 4-dicarboxylic ester and 8-15 parts of polyhydric alcohol. The hyaluronic acid is a mixture of macromolecular hyaluronic acid, micromolecular hyaluronic acid, cross-linked hyaluronic acid and high-affinity hyaluronic acid, and the mass ratio of the hyaluronic acid to the high-affinity hyaluronic acid is 1 (1-3) to (2-4) to (1-4); the polyhydric alcohol is composed of one or more of glycerol, propylene glycol, polyethylene glycol, sorbitol, 1, 3-butanediol, 1, 2-hexanediol and pentanediol, and preferably glycerol.
CN112336649A discloses a method for preparing skin co-permeation carrier of ceramide and fat-soluble active substance and a product thereof, wherein the skin co-permeation carrier comprises ceramide, fat-soluble active substance, phospholipid, cholesterol, fatty acid, phytosphingosine, liquid lipid, solid lipid, polyalcohol and water. The polyalcohol is one or more of glycerol, butanediol, sorbitol, pentaerythritol and xylitol. The positive charge of the carrier, and the ternary penetration-promoting system (ceramide, cholesterol and fatty acid) can obviously improve the penetration amount of ceramide in the skin stratum corneum, exert the effects of enhancing skin hydration and improving stratum corneum lipid fluidity, further promote the skin penetration of fat-soluble active substances in the carrier and achieve the aim of co-penetration.
CN107441066A discloses a transdermal absorption patch, which comprises a back lining layer, a drug storage layer and a protective layer; wherein the medicine storage layer comprises an adhesive composition, a plasticizer, a penetration enhancer, a moisturizing plasticizer and an active medicine. The penetration enhancer is prepared by combining more than two polyalcohol compounds and at least one lactic acid compound or at least one fatty acid ester compound. The polyol compound includes low-carbon polyol compounds such as 1, 2-propylene glycol, 1, 3-propylene glycol, 1, 2-butylene glycol, 1, 3-butylene glycol, 1, 4-butylene glycol and the like, and polyol polymers which are liquid at normal temperature such as polyethylene glycol 200, 400, 600, polypropylene glycol 200, 400, 600 and the like.
As can be seen from the prior art, the existing penetration enhancer is mainly prepared by compounding polyalcohol and other various components, so that the penetration enhancing effect of the product is achieved, and heavy burden can be caused to the skin. Furthermore, the penetration enhancer has a single function, and cosmetics having an effect of improving the skin are required to have not only a good penetration enhancing effect but also an effect of improving the final effect of the skin in consideration of absorbency, spreadability, stickiness, moisture retention, and the like.
Disclosure of Invention
In view of the deficiencies of the prior art, the present invention aims to provide a polyol composition and its use in cosmetics, in particular a polyol composition having a significant penetration enhancing effect and its use in cosmetics. The polyol composition has a good permeation promoting effect under the condition that the polyol composition is not required to be compounded with other permeation promoting functional components, and helps to improve the absorbability and the moisture retention of a product and reduce the sticky feeling of the product.
In order to achieve the purpose, the invention adopts the following technical scheme:
in a first aspect, the present invention provides a polyol composition comprising: panthenol, 1, 2-propanediol, 1, 3-propanediol, and polyethylene glycol.
The invention creatively combines four specific polyols of panthenol, 1, 2-propylene glycol, 1, 3-propylene glycol and polyethylene glycol to form a polyol composition, and the polyol composition is added into skin care matrixes with different effects, so that the problem of transdermal absorption of skin care effect components can be remarkably improved, the efficacy of the product is improved, the absorbability and the moisture retention of the product are improved, the smearing feeling and the sticky feeling of the product are improved, no additional preservative is required, and the skin care composition is safe and mild and has no stimulation to skin.
Preferably, the mass ratio of the panthenol, the 1, 2-propylene glycol, the 1, 3-propylene glycol and the polyethylene glycol is (1-8): (5-20): 5-20).
When the mass ratio of panthenol, 1, 2-propylene glycol, 1, 3-propylene glycol and polyethylene glycol satisfies the above specific range, the polyol composition has better effects in improving the problem of transdermal absorption of skin care efficacy components, improving the absorbability and moisture retention of the product. And (1-5): (10-20): (10-20): (10-20) is the most significant range of effect.
The term (1-8) means that the specific value can be selected to be 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5 or 8, etc.
The (5-20) means that specific values can be selected to be 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18 or 20, and the like.
Other specific point values within the above numerical ranges can be selected, and are not described in detail herein.
Further preferably, the mass ratio of the panthenol, the 1, 2-propylene glycol and the 1, 3-propylene glycol to the polyethylene glycol is (1-5): (10-20).
Preferably, the polyol composition further comprises any one or a combination of at least two of glycerol, butanediol, or 1, 2-hexanediol; the combination of at least two of the above-mentioned compounds, such as the combination of glycerin and butylene glycol, the combination of butylene glycol and 1, 2-hexanediol, the combination of glycerin and 1, 2-hexanediol, etc., can be selected in any combination manner, and thus, the details are not repeated herein. A combination of glycerol, butylene glycol and 1, 2-hexanediol is preferred.
The effect of improving the skin-care functional component in the aspects of percutaneous absorption, improving the product absorptivity and moisture retention can be further improved by further adding any one or the combination of at least two of glycerin, butanediol or 1, 2-hexanediol into the polyol composition.
Preferably, the mass ratio of glycerol to panthenol is (5-13): (1-8), preferably (5-10): (1-5);
wherein, (1-8) means that the specific value can be selected to be 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5 or 8, etc.; (5-13) means that the specific value can be selected to be 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, 10, 10.5, 11, 12, or 13, etc.; other specific point values within the above numerical ranges can be selected, and are not described in detail herein.
Preferably, the mass ratio of the butanediol to the panthenol is (5-15): (1-8), preferably (8-15): (1-5);
wherein, (1-8) means that the specific value can be selected to be 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5 or 8, etc.; (5-15) means that the specific value can be selected to be 5, 5.5, 6, 6.5, 7, 7.5, 8, 9, 10, 11, 12, 13, 14, or 15, etc.; other specific point values within the above numerical ranges can be selected, and are not described in detail herein.
Preferably, the mass ratio of the 1, 2-hexanediol to the panthenol is (0.5-3): 1-8, preferably (0.5-2): 1-5.
Wherein, (1-8) means that the specific value can be selected to be 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5 or 8, etc.; (0.5-3) means that the specific value can be selected to be 0.5, 1, 1.5, 2, 2.5 or 3, etc.; other specific point values within the above numerical ranges can be selected, and are not described in detail herein.
When the addition amount of the glycerin, the butanediol or the 1, 2-hexanediol meets the specific requirements, the skin-care functional component has better effects on improving the transdermal absorption problem of the skin-care functional component, improving the absorbability of the product and keeping moisture.
Preferably, the polyol composition further comprises dipropylene glycol and/or pentanediol, preferably a combination of dipropylene glycol and pentanediol.
The further addition of dipropylene glycol and/or pentanediol to the aforementioned polyol composition can increase the moisture retention of the composition and improve the skin feel, mildness, and non-irritation of the final product.
The preparation process of the polyol composition is simple, only needs to be simply and uniformly mixed, is convenient to operate, and is very suitable for industrial production.
In a second aspect, the present invention provides the use of a polyol composition as described in the first aspect in the preparation of a cosmetic product.
The polyol composition can be widely used for being added into skin care matrixes with different efficacies, and has good compatibility.
Preferably, the polyol composition is added in an amount of 30-90% in the cosmetic, such as 30%, 40%, 50%, 60%, 70%, 80%, 90%, etc., and other specific values in the numerical range can be selected, which is not described in detail herein. Preferably 40 to 80%, and more preferably 50 to 80%.
In a third aspect, the invention provides a whitening and skin-brightening skin care product, which is prepared from the following raw materials in percentage by mass: the polyol composition of the first aspect is 50-80% (e.g., 50%, 55%, 60%, 65%, 70%, 75%, 80%, etc.), the whitening skin lightening base is 0.1-10% (0.1%, 0.5%, 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, etc.), water.
Preferably, the whitening and skin-lightening base comprises any one of niacinamide, 3-o-ethyl ascorbic acid, glutathione, ergothioneine, idebene, tocopherol, resveratrol or retinol or a combination of at least two of the same.
In a fourth aspect, the invention provides a moisturizing and skin-care product, which is prepared from the following raw materials in percentage by mass: the polyol composition of the first aspect is 50-80% (e.g., 50%, 55%, 60%, 65%, 70%, 75%, 80%, etc.), the moisturizing base is 0.05-10% (e.g., 0.05%, 0.1%, 0.5%, 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, etc.), water.
Preferably, the moisturizing and moisturizing substrate comprises any one or a combination of at least two of ectoin, sodium hyaluronate, amino acid, sodium alginate, beta-glucan, ceramide, betaine, squalane or jojoba seed oil.
In a fifth aspect, the invention provides a skin-tightening skin care product, which comprises the following raw materials in percentage by mass: the polyol composition of the first aspect can be 50-80% (e.g., 50%, 55%, 60%, 65%, 70%, 75%, 80%, etc.), the firming skin substrate 0.05-10% (e.g., 0.05%, 0.1%, 0.5%, 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, etc.), water.
Preferably, the tightening skin matrix comprises any one of or a combination of at least two of a blue-copper peptide, hydroxy-pinacolone retinoic acid ester, silanediol salicylate, hydrolyzed collagen, hydroxypropyl tetrahydropyran triol, or polypeptide.
Compared with the prior art, the invention has the following beneficial effects:
the invention creatively combines four specific polyols of panthenol, 1, 2-propylene glycol, 1, 3-propylene glycol and polyethylene glycol to form a polyol composition, and the polyol composition is added into skin care matrixes with different effects, so that the problem of transdermal absorption of skin care effect components can be remarkably improved, the efficacy of the product is improved, the absorbability and the moisture retention of the product are improved, the smearing feeling and the sticky feeling of the product are improved, no additional preservative is required, and the skin care composition is safe and mild and has no stimulation to skin.
Detailed Description
To further illustrate the technical means and effects of the present invention, the following further describes the technical solution of the present invention with reference to the preferred embodiments of the present invention, but the present invention is not limited to the scope of the embodiments.
The polyethylene glycol referred to in the following examples and comparative examples was polyethylene glycol (Mw ═ 400); the butanediol is 1, 3-butanediol; the pentanediol is 1, 2-pentanediol; ergothioneine was obtained from shanghai ketjen technologies ltd,the model isAmycopterinNicotinamide is available from Longsha under the type Niacinamide feed grade; glutathione is purchased from Viqi technology and has a model number ofPGSH glutathione Plus.
Example 1
This example provides a polyol composition, comprising, by weight, 40g of panthenol, 3 parts of 1, 2-propanediol, 15 parts of 1, 3-propanediol, and 15 parts of polyethylene glycol, wherein the components are uniformly mixed at 25 ℃.
Example 2
This example provides a polyol composition, comprising, by weight, 40g of panthenol, 8 parts of 1, 2-propanediol, 8 parts of 1, 3-propanediol, and 8 parts of polyethylene glycol, wherein the components are uniformly mixed at 25 ℃.
Example 3
This example provides a polyol composition, which comprises, by weight, 40g of a total polyol composition, 3 parts of panthenol, 15 parts of 1, 2-propanediol, 15 parts of 1, 3-propanediol, 15 parts of polyethylene glycol, and 8 parts of glycerol, and the components are uniformly mixed at 25 ℃.
Example 4
This example provides a polyol composition, which comprises, by weight, 40g of a total polyol composition, 3 parts of panthenol, 15 parts of 1, 2-propanediol, 15 parts of 1, 3-propanediol, 15 parts of polyethylene glycol, and 10 parts of butanediol, and the components are uniformly mixed at 25 ℃.
Example 5
This example provides a polyol composition, which comprises, by weight, 40g of panthenol, 15 parts of 1, 2-propanediol, 15 parts of 1, 3-propanediol, 15 parts of polyethylene glycol, and 1.5 parts of 1, 2-hexanediol, and the components are uniformly mixed at 25 ℃.
Example 6
This example provides a polyol composition, which comprises, by weight, 40g of a total polyol composition, 3 parts of panthenol, 15 parts of 1, 2-propanediol, 15 parts of 1, 3-propanediol, 15 parts of polyethylene glycol, 8 parts of glycerol, 10 parts of butanediol, and 1.5 parts of 1, 2-hexanediol, and the components are uniformly mixed at 25 ℃.
Example 7
This example provides a polyol composition, which comprises, by weight, 40g of a total polyol composition, 3 parts of panthenol, 15 parts of 1, 2-propanediol, 15 parts of 1, 3-propanediol, 15 parts of polyethylene glycol, 8 parts of glycerol, 10 parts of butanediol, 1.5 parts of 1, 2-hexanediol, 3 parts of dipropylene glycol, and 2 parts of pentanediol, and the components are uniformly mixed at 25 ℃.
Comparative example 1
This comparative example provides a total mass of 40g of panthenol.
Comparative example 2
This comparative example provides a total mass of 40g of 1, 2-propanediol.
Comparative example 3
This comparative example provides a total mass of 40g of 1, 3-propanediol.
Comparative example 4
This comparative example provides a total mass of 40g of polyethylene glycol.
Comparative example 5
This comparative example provides a polyol composition having a total mass of 40g and consisting of the same components as in example 1 except that panthenol was replaced with sorbitol of equal mass, and the other conditions were kept unchanged. The components are mixed evenly at 25 ℃.
Comparative example 6
This comparative example provides a polyol composition having a total mass of 40g and consisting of the same components as in example 1 except that panthenol was replaced with glycerol of equal mass, and the other conditions were kept unchanged. The components are mixed evenly at 25 ℃.
Application example 1
The application example provides a whitening and skin-brightening skin-care essence which comprises, by mass, 70% of the polyol composition prepared in example 1, 3% of nicotinamide, 0.5% of glutathione, 0.5% of ergothioneine and deionized water to make up to 100%.
The preparation method comprises the following steps:
(1) firstly, heating water to 85 ℃, preserving heat for 30min, and then sterilizing;
(2) then cooling to 45 ℃, adding the mixed polyol composition, and stirring uniformly;
(3) finally, the nicotinamide, the glutathione and the ergothioneine are added, the temperature is restored to 25 ℃, and qualified discharge is carried out.
Application examples 2 to 7
The present application example provides six kinds of whitening and skin-lightening skin care essences, which are different from the application example 1 only in that the polyol composition prepared in example 1 was replaced with the polyol compositions prepared in examples 2 to 7, and the others were kept unchanged. The preparation method is the same as in application example 1.
Comparative application examples 1 to 6
The comparative application example provides six kinds of whitening and skin-brightening skin care essences, the components of which are different from those of application example 1 only in that the polyol composition prepared in example 1 is replaced by the polyol compositions prepared in comparative examples 1-6, and the others are kept unchanged. The preparation method is the same as in application example 1.
Comparative application example 7
The comparative application example provides a whitening and skin-brightening skin care essence which is different from the application example 1 only in that the polyol composition prepared in the example 1 is not contained, and the rest of the essence are kept unchanged.
Test example 1
Safety tests were performed on the whitening, skin-lightening and skin-care essences of application examples 1 to 7 and comparative application examples 1 to 7:
selecting 42 volunteers with ages of 25-40 years for testing, randomly dividing the volunteers into 14 groups, 3 persons in each group, distributing a sample for each group of volunteers to carry out a closed spot-sticking test, dripping about 0.025mL of a tested sample into a spot tester, externally applying a special adhesive tape to the back of the test subject, removing the tested sample after 24 hours, observing skin reactions after 0.5, 24 and 48 hours after the removal respectively, and recording the results according to the skin reaction grading standard in technical Specification for cosmetic safety (2015 edition).
The result of the human body skin patch test shows that: adverse reactions to skin appear in 0 cases, which shows that the whitening and skin-brightening skin-care essence disclosed by the invention is safe and non-irritant to skin.
Test example 2
The whitening and skin-brightening skin care essences of application examples 1 to 7 and comparative application examples 1 to 7 were subjected to a whitening and skin-brightening efficacy test:
the experimental principle is as follows: the change in skin color can be measured using a skin complexion measuring instrument. The currently widely adopted measuring method for quantifying skin color is to measure the change of skin color by a colorimetric system (Lab colorimetric system) specified by the International Commission on illumination (CIE), and the method has accurate quantification, can reflect the multidimensional change of a skin color space, and ensures that the skin color is quantified more reliably. The test indexes are the MI value of the skin melanin content (the higher the measured value is, the higher the melanin content in the skin is), the L value of the skin whiteness/brightness and the ITA degree (the L value indicates that L is white balance, the larger the value is, the more white the color is, the ITA degree value is the individual type angle of the skin, and the larger the ITA degree value is, the brighter the skin). Therefore, the whitening effect of the cosmetic can be judged by measuring the melanin content of the skin stratum corneum and the skin chromaticity.
△MI=Tn-T0(ii) a In the formula TnThe time-varying value of the tested area; t is0Is the initial value of the tested area.
△L*=Tn-T0(ii) a In the formula TnThe time-varying value of the tested area; t is0Is the initial value of the tested area.
△ITA°=Tn-T0(ii) a In the formula TnThe time-varying value of the tested area; t is0Is the initial value of the tested area.
An experimental instrument: multifunctional skin test system (MPA580, CK, germany); skin color difference test probe (CL400, CK, germany); skin red melanin tester and test probe (Mexameter MX18, CK, germany).
The experimental method comprises the following steps: 70 volunteers of 25-45 years old are selected, and the skin is mixed type skin, wherein 28 volunteers are male and 42 volunteers are female. The test subjects were respectively applied to the face twice a day, and 2mg of the product was used in the morning and evening, and the application was continued for 4 weeks, and the skin of the face was subjected to the analysis of melanin and color difference data collection before sampling, and the data was used as the background value of the skin. During the experiment, the subject was not able to apply any other cosmetic product at the experimental site. Data acquisition was performed at week 4. The changes of skin whiteness (brightness) and skin melanin content of the subjects before and after the application of the cosmetics are evaluated, so that the whitening and skin-brightening effects of the product are determined. The results are shown in tables 1,2 and 3 (all data are presented as mean values).
TABLE 1
TABLE 2
TABLE 3
From the data results of tables 1-3, it can be seen that: compared with comparative application examples 1 to 7, the products of application examples 1 to 7 have better whitening and skin brightening effects, and the whitening and skin brightening essence has remarkable whitening and skin brightening effects, wherein the effects of application example 6 and application example 7 are optimal, and the effect of application example 2 is slightly poorer than that of other application examples. Data analysis of application example 1 and comparative application example 7 shows that the whitening and skin-lightening effect of the polyol composition according to the present invention is significantly improved compared to the effect of the polyol composition without the addition of the polyol composition, which indicates that the polyol composition according to the present invention can effectively promote penetration and absorption of whitening actives.
Test example 3
The volunteers in test example 2 simultaneously evaluated the whitening and skin-lightening essence of application examples 1 to 7 and comparative application examples 1 to 7 in several dimensions of smell, texture in appearance, feeling of smearing, absorbency, stickiness, moisture retention and skin softness, and the rating standards and grades were as follows:
the results are shown in table 4 (all data are presented as mean):
TABLE 4
From the data in table 4, it can be seen that: compared with the comparative application examples 1-7, the products of the application examples 1-7 have better evaluation on the indexes of smell, appearance texture, smearing feeling, absorbability, stickiness, moisture retention and skin softness, and the polyol composition disclosed by the invention is added into the whitening and skin-brightening skin-care matrix, so that the problem of transdermal absorption of functional components is improved, the efficacy of the products is improved, and the absorbability, the moisture retention and the smearing feeling and the stickiness of the products are improved. The effects of application example 6 and application example 7 are the best, and the effect of application example 2 is slightly worse than that of other application examples.
Application example 8
The application example provides a moisturizing and skin-care essence which comprises, by mass, 70% of the polyol composition prepared in example 1, 3% of sodium alginate, 0.5% of squalane, 0.5% of sodium hyaluronate, and the balance of deionized water to 100%.
The preparation method comprises the following steps:
(1) firstly, heating water to 85 ℃, preserving heat for 30min, and then sterilizing;
(2) then cooling to 45 ℃, adding the mixed polyol composition, and stirring uniformly;
(3) and finally, adding the sodium alginate, squalane and sodium hyaluronate, recovering to 25 ℃, and discharging after the inspection is qualified.
Application examples 9 to 14
The present application example provides six moisturizing and skin-care essences whose ingredients differ from application example 8 only in that the polyol composition prepared in example 1 was replaced with the polyol compositions prepared in examples 2 to 7, and the others were all kept unchanged. The preparation method is the same as in application example 8.
Comparative application examples 8 to 13
The present comparative application example provides six moisturizing skin care essences, the components of which are different from those of application example 8 only in that the polyol composition prepared in example 1 is replaced with the polyol compositions prepared in comparative examples 1 to 6, and the others are kept unchanged. The preparation method is the same as in application example 8.
Comparative application example 14
The comparative application example provides a moisturizing and skin-care essence which is different from the application example 8 only in that the polyol composition prepared in example 1 is not contained, and the rest of the essence is kept unchanged.
Test example 3
The water replenishing and moisturizing skin care essence of the application examples 8-14 and the comparative application examples 8-14 was subjected to a safety test:
selecting 42 volunteers with ages of 25-40 years for testing, randomly dividing the volunteers into 14 groups, 3 persons in each group, distributing a sample for each group of volunteers to carry out a closed spot-sticking test, dripping about 0.025mL of a tested sample into a spot tester, externally applying a special adhesive tape to the back of the test subject, removing the tested sample after 24 hours, observing skin reactions after 0.5, 24 and 48 hours after the removal respectively, and recording the results according to the skin reaction grading standard in technical Specification for cosmetic safety (2015 edition).
The result of the human body skin patch test shows that: adverse reactions to skin appear in 0 cases, which shows that the water-replenishing, moisture-preserving and skin-care essence disclosed by the invention is safe and non-irritant to skin.
Test example 4
And carrying out moisturizing and moisturizing efficacy tests on the moisturizing and moisturizing essence of the application examples 8-14 and the comparative application examples 8-14:
the experimental principle is as follows: based on the fact that the dielectric constant of water and other substances changes greatly, according to the difference of water content, a measuring capacitor with a proper shape changes along with the change of capacitance of the skin, and the moisture content of the skin can be measured when the capacitance of the skin is in a measuring range.
An experimental instrument: the test instrument is Corneometer (CK) and is used for measuring the moisture content of the skin; before each test, the skin is cleaned by water, and the test is carried out after the skin is dried after 30 min;
the experimental method comprises the following steps: the 4 areas of the test, each 1X 1cm in size, were marked on the face of the subject using a template prepared beforehand2The other half face was used as a blank control area, and samples were applied to all test areas at a rate of 2mg/cm2. Before the basic value test, the skin is cleaned by water, the skin is dried after 30min, and then the measurement is carried out, and the measurement is carried out for 1h, 2h and 4h after the sample is used;
the temperature is controlled at 22 +/-2 ℃ and the relative humidity is 50 +/-5% during the test process.
The results are shown in table 5 (all data are presented as mean values).
TABLE 5
From the data in table 5, it can be seen that: compared with comparative application examples 8-14, the products of application examples 8-14 have more remarkable moisturizing and moisturizing effects, and the polyol composition disclosed by the invention is added into a moisturizing and moisturizing skin care substrate, so that the penetration and absorption of moisturizing and moisturizing effect components can be effectively promoted, and the efficacy of the product is improved. The application 13 and the application 14 have the best effect, and the application 9 has a slightly worse effect compared with other applications.
The applicant states that the present invention is illustrated by the above examples of a polyol composition and its use in cosmetics, but the present invention is not limited to the above examples, i.e. it is not meant to imply that the present invention must be practiced in reliance thereon. It should be understood by those skilled in the art that any modification of the present invention, equivalent substitutions of the raw materials of the product of the present invention, addition of auxiliary components, selection of specific modes, etc., are within the scope and disclosure of the present invention.
The preferred embodiments of the present invention have been described in detail, however, the present invention is not limited to the specific details of the above embodiments, and various simple modifications may be made to the technical solution of the present invention within the technical idea of the present invention, and these simple modifications are within the protective scope of the present invention.
It should be noted that the various technical features described in the above embodiments can be combined in any suitable manner without contradiction, and the invention is not described in any way for the possible combinations in order to avoid unnecessary repetition.
Claims (10)
1. A polyol composition, characterized in that said polyol composition comprises: panthenol, 1, 2-propanediol, 1, 3-propanediol, and polyethylene glycol.
2. The polyol composition of claim 1 wherein the mass ratio of panthenol, 1, 2-propanediol, 1, 3-propanediol, and polyethylene glycol is (1-8): (5-20);
preferably, the mass ratio of the panthenol, the 1, 2-propylene glycol, the 1, 3-propylene glycol and the polyethylene glycol is (1-5): 10-20.
3. The polyol composition of claim 1 or 2 further comprising any one or a combination of at least two of glycerol, butanediol, or 1, 2-hexanediol; a combination of glycerol, butylene glycol and 1, 2-hexanediol is preferred.
4. The polyol composition of claim 3 wherein the mass ratio of glycerol to panthenol is (5-13): (1-8), preferably (5-10): (1-5);
preferably, the mass ratio of the butanediol to the panthenol is (5-15): (1-8), preferably (8-15): (1-5);
preferably, the mass ratio of the 1, 2-hexanediol to the panthenol is (0.5-3): 1-8, preferably (0.5-2): 1-5.
5. The polyol composition of any of claims 1 to 4, wherein said polyol composition further comprises dipropylene glycol and/or pentanediol, preferably a combination of dipropylene glycol and pentanediol.
6. Use of the polyol composition according to any of claims 1 to 5 for the preparation of a cosmetic product.
7. Use according to claim 6, wherein the polyol composition is added to the cosmetic in an amount of 30-90%, preferably 40-80%, further preferably 50-80%.
8. The whitening and skin-brightening skin care product is characterized by comprising the following preparation raw materials in percentage by mass: the polyol composition of any of claims 1-5 from 50-80%, a whitening skin lightening base from 0.1-10%, water;
preferably, the whitening and skin-lightening base comprises any one of niacinamide, 3-o-ethyl ascorbic acid, glutathione, ergothioneine, idebene, tocopherol, resveratrol or retinol or a combination of at least two of the same.
9. The moisturizing skin care product is characterized by comprising the following preparation raw materials in percentage by mass: the polyol composition of any of claims 1-5, from 50-80%, the moisturizing base from 0.05-10%, water;
preferably, the moisturizing and moisturizing substrate comprises any one or a combination of at least two of ectoin, sodium hyaluronate, amino acid, sodium alginate, beta-glucan, ceramide, betaine, squalane or jojoba seed oil.
10. The skin-tightening skin care product is characterized by comprising the following raw materials in percentage by mass: the polyol composition of any of claims 1-5, from 50-80%, firm skin substrate 0.05-10%, water;
preferably, the tightening skin matrix comprises any one of or a combination of at least two of a blue-copper peptide, hydroxy-pinacolone retinoic acid ester, silanediol salicylate, hydrolyzed collagen, hydroxypropyl tetrahydropyran triol, or polypeptide.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110473784.XA CN113116750A (en) | 2021-04-29 | 2021-04-29 | Polyol composition and application thereof in cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110473784.XA CN113116750A (en) | 2021-04-29 | 2021-04-29 | Polyol composition and application thereof in cosmetics |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113116750A true CN113116750A (en) | 2021-07-16 |
Family
ID=76780958
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110473784.XA Pending CN113116750A (en) | 2021-04-29 | 2021-04-29 | Polyol composition and application thereof in cosmetics |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113116750A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114392323A (en) * | 2021-12-30 | 2022-04-26 | 上海家化联合股份有限公司 | Anti-glycation traditional Chinese medicine extract |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4970220A (en) * | 1982-05-17 | 1990-11-13 | S. C. Johnson & Son, Inc. | Skin conditioning composition |
MXPA03002169A (en) * | 2000-09-13 | 2003-07-24 | Procter & Gamble | Cosmetic compositions. |
US20190282487A1 (en) * | 2017-04-06 | 2019-09-19 | Hunan Yujia Cosmetics Manufacturing Co., Ltd. | Moisturizing composition and application thereof in preparation of moisturizing cosmetic product |
CN112641671A (en) * | 2021-01-28 | 2021-04-13 | 广州碧思特生物科技有限公司 | Moisturizing composition and preparation process thereof |
-
2021
- 2021-04-29 CN CN202110473784.XA patent/CN113116750A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4970220A (en) * | 1982-05-17 | 1990-11-13 | S. C. Johnson & Son, Inc. | Skin conditioning composition |
MXPA03002169A (en) * | 2000-09-13 | 2003-07-24 | Procter & Gamble | Cosmetic compositions. |
CN1454080A (en) * | 2000-09-13 | 2003-11-05 | 宝洁公司 | Cosmetic compositions |
US20190282487A1 (en) * | 2017-04-06 | 2019-09-19 | Hunan Yujia Cosmetics Manufacturing Co., Ltd. | Moisturizing composition and application thereof in preparation of moisturizing cosmetic product |
CN112641671A (en) * | 2021-01-28 | 2021-04-13 | 广州碧思特生物科技有限公司 | Moisturizing composition and preparation process thereof |
Non-Patent Citations (2)
Title |
---|
姚静: "《药用辅料应用指南》", 31 August 2011, 中国医药科技出版社 * |
广州众木成林商贸有限公司: "霏丹妮斯深润补湿按摩精华", 《国产非特殊用途化妆品备案服务平台》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114392323A (en) * | 2021-12-30 | 2022-04-26 | 上海家化联合股份有限公司 | Anti-glycation traditional Chinese medicine extract |
CN114392323B (en) * | 2021-12-30 | 2023-06-30 | 上海家化联合股份有限公司 | Anti-glycation traditional Chinese medicine extract |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ITTO960710A1 (en) | USE OF VITAMIN C OR ITS DERIVATIVES OR ANALOGS TO STIMULATE THE SYNTHESIS OF SKIN ELASTIN. | |
CN111511366A (en) | Ascorbic acid and/or external composition containing salt thereof | |
CN110974767A (en) | Composition for skin barrier regeneration repair and application thereof | |
KR101794555B1 (en) | Cosmetic composition for protecting lip comprising natural ceramide and rosa canina fruit oil | |
CN113116750A (en) | Polyol composition and application thereof in cosmetics | |
CN113786357B (en) | Gel with sun-proof, instant and long-acting wrinkle-smoothing effects and preparation method thereof | |
EP3661483A1 (en) | 1,4: 3,6 dianhydrohexitols for moisturising the skin | |
EP2720671B1 (en) | Translucent and syrupy cosmetic composition | |
KR100814035B1 (en) | Oil-Dispersion Type Cosmetic Composition for Improving Lip Wrinkles Containing Adenosin Base | |
KR101050237B1 (en) | Functional Cosmetic Composition Using Pine Bark Extract | |
JPS6351311A (en) | Skin cosmetic | |
KR101017922B1 (en) | Cosmetic composition containing licorice extract and natural thickeners for skin whitening | |
KR102036141B1 (en) | Cosmetic Composition Containing Cholesteric Liquid Crystal With Dual Capsule Process | |
CN115813783A (en) | Water-oil double-agent instant emulsification type high-moisture-retention skin-brightening face mask and preparation method thereof | |
CN113662882B (en) | Whitening, spot-fading and tightening essence and preparation method thereof | |
CN115006274A (en) | Water-oil two-phase smoothing toner added with copper vicryl peptide and preparation method | |
CN115350125A (en) | Mild and non-irritant multifunctional composition containing plant bud extract, skin care product and preparation method and application of composition | |
CN114288201A (en) | Composition for removing under-eye puffiness and fading black eye circles and preparation method and application thereof | |
CN107334691A (en) | A kind of whitening cosmetic compound | |
CN112190576A (en) | Composition of skin external preparation, skin external preparation and preparation method thereof | |
KR101011356B1 (en) | A stick type cosmetic compound containing rosmarinic acid | |
CN115778872B (en) | Composition with acne removing and repairing effects, and preparation method and application thereof | |
KR101221270B1 (en) | Dual structure lipstick comprising the emulsifying base of water in oil type having the improved water retention and stability | |
KR102132538B1 (en) | Manufactureing method for cosmetic booster and cosmetic booster by the same and cosmetic composition having the same using rice bran extract | |
CN115813826B (en) | Compact anti-wrinkle composition and application thereof in cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210716 |
|
RJ01 | Rejection of invention patent application after publication |